Cargando…
Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
Oncolytic virus (OV) is a new therapeutic strategy for cancer treatment. OVs can selectively infect and destroy cancer cells, and therefore act as an in situ cancer vaccine by releasing tumor-specific antigens. Moreover, they can remodel the tumor microenvironment toward a T cell-inflamed phenotype...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589893/ https://www.ncbi.nlm.nih.gov/pubmed/33086754 http://dx.doi.org/10.3390/ijms21207743 |